Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

A hypothetical molecular mechanism for TRPV1 activation that invokes rotation of an S6 asparagine.

Kasimova MA, Yazici AT, Yudin Y, Granata D, Klein ML, Rohacs T, Carnevale V.

J Gen Physiol. 2018 Nov 5;150(11):1554-1566. doi: 10.1085/jgp.201812124. Epub 2018 Oct 17.

PMID:
30333107
2.

Structural insights on TRPV5 gating by endogenous modulators.

Hughes TET, Pumroy RA, Yazici AT, Kasimova MA, Fluck EC, Huynh KW, Samanta A, Molugu SK, Zhou ZH, Carnevale V, Rohacs T, Moiseenkova-Bell VY.

Nat Commun. 2018 Oct 10;9(1):4198. doi: 10.1038/s41467-018-06753-6.

3.

The Efficacy of Intravitreal Bevacizumab in Vitreous Hemorrhage of Diabetic Subjects.

Alagöz C, Yıldırım Y, Kocamaz M, Baz Ö, Çiçek U, Çelik B, Demirkale Hİ, Yazıcı AT, Taşkapılı M.

Turk J Ophthalmol. 2016 Oct;46(5):221-225. doi: 10.4274/tjo.82542. Epub 2016 Oct 17.

4.

The natural course of idiopathic epiretinal membranes with optical coherence tomography follow-up.

Yazıcı AT, Çekiç O.

Graefes Arch Clin Exp Ophthalmol. 2016 Dec;254(12):2485-2486. Epub 2016 Nov 10. No abstract available.

PMID:
27834000
5.

Ocular Pulse Amplitude and Retinal Vessel Caliber Changes after Intravitreal Dexamethasone Implant.

Yilmaz I, Perente I, Kesim C, Saracoglu B, Yazici AT, Taskapili M.

Middle East Afr J Ophthalmol. 2016 Jul-Sep;23(3):250-2. doi: 10.4103/0974-9233.186112.

6.

Relationship between Peeled Internal Limiting Membrane Area and Anatomic Outcomes following Macular Hole Surgery: A Quantitative Analysis.

Goker YS, Koc M, Yuksel K, Yazici AT, Demir A, Gunes H, Ozpinar Y.

J Ophthalmol. 2016;2016:5641273. doi: 10.1155/2016/5641273. Epub 2016 Jun 16.

7.

Changes in pupil size following panretinal retinal photocoagulation: conventional laser vs pattern scan laser (PASCAL).

Yilmaz I, Perente I, Saracoglu B, Yazici AT, Taskapili M.

Eye (Lond). 2016 Oct;30(10):1359-1364. doi: 10.1038/eye.2016.135. Epub 2016 Jul 8.

8.

Intravitreal ranibizumab in the treatment of choroidal neovascularization secondary to morning glory syndrome in a child.

Özkaya A, Yilmaz I, Alkin Z, Karakucuk Y, Yazici AT.

Saudi J Ophthalmol. 2016 Apr-Jun;30(2):140-3. doi: 10.1016/j.sjopt.2016.02.004. Epub 2016 Feb 16.

9.

Anti-Vascular Endothelial Growth Factor Treatment for Proliferative Macular Telangiectasia Type 2.

Alkin Z, Yilmaz I, Ozkaya A, Yazici AT.

Middle East Afr J Ophthalmol. 2016 Apr-Jun;23(2):222-4. doi: 10.4103/0974-9233.171773.

10.

Choroidal Thickness, Photoreceptor Thickness, and Retinal Vascular Caliber Alterations in Dark Adaptation.

Alagöz C, Pekel G, Alagöz N, Sayın N, Yüksel K, Yıldırım Y, Yazıcı AT.

Curr Eye Res. 2016 Dec;41(12):1608-1613. Epub 2016 May 9.

PMID:
27159535
11.

The time of resolution and the rate of recurrence in acute central serous chorioretinopathy following spontaneous resolution and low-fluence photodynamic therapy: a case-control study.

Ozkaya A, Alkin Z, Ozveren M, Yazici AT, Taskapili M.

Eye (Lond). 2016 Jul;30(7):1005-10. doi: 10.1038/eye.2016.79. Epub 2016 Apr 22.

12.

The role of indocyanine green angiography imaging in further differential diagnosis of patients with nAMD who are morphologically poor responders to ranibizumab in a real-life setting.

Ozkaya A, Alagoz C, Garip R, Alkin Z, Perente I, Yazici AT, Taskapili M.

Eye (Lond). 2016 Jul;30(7):958-65. doi: 10.1038/eye.2016.71. Epub 2016 Apr 15.

13.

Dexamethasone implant in pseudophakic and nonglaucomatous subgroup of diabetic macular edema patients: a real life experience.

Ozkaya A, Alagoz C, Alagoz N, Gunes H, Yilmaz I, Perente I, Yazici AT, Taskapili M.

Eur J Ophthalmol. 2016 Jun 10;26(4):351-5. doi: 10.5301/ejo.5000725. Epub 2015 Dec 16.

PMID:
26692061
14.

Changes in Pupil Size Following Panretinal and Focal/Grid Retinal Photocoagulation: Automatic Infrared Pupillometry Study.

Yilmaz I, Faiz M, Saracoglu B, Yazici AT.

J Ocul Pharmacol Ther. 2016 Apr;32(3):172-7. doi: 10.1089/jop.2015.0080. Epub 2015 Nov 18.

PMID:
26580579
15.

Immediate Intraocular Pressure Changes Following Intravitreal Dexamethasone Implant.

Alagöz N, Alagöz C, Yılmaz I, Yıldırım Y, Baz Ö, Altan Ç, Yazıcı AT, Taşkapılı M.

J Ocul Pharmacol Ther. 2016 Jan-Feb;32(1):44-9. doi: 10.1089/jop.2015.0087. Epub 2015 Nov 5.

PMID:
26540554
16.

Peripapillary Focal Choroidal Excavation in Association With Central Serous Chorioretinopathy.

Alagöz C, Alagöz N, Yüksel K, Yildirim Y, Yazici AT.

Retina. 2016 Apr;36(4):e27-8. doi: 10.1097/IAE.0000000000000854. No abstract available.

PMID:
26529552
17.

Comparison of photoreceptor outer segment length in diabetic and idiopathic epiretinal membranes.

Yüksel K, Karaküçük Y, Özkaya A, Pekel G, Baz Ö, Alagöz C, Yazıcı AT.

Eye (Lond). 2015 Nov;29(11):1446-52. doi: 10.1038/eye.2015.133. Epub 2015 Jul 17.

18.

23 gauge pars plana vitrectomy for the removal of retained intraocular foreign bodies.

Yuksel K, Celik U, Alagoz C, Dundar H, Celik B, Yazıcı AT.

BMC Ophthalmol. 2015 Jul 16;15:75. doi: 10.1186/s12886-015-0067-2.

19.

Steroid-induced central serous chorioretinopathy in a patient with non-arteritic anterior ischemic optic neuropathy.

Alkin Z, Yilmaz I, Ozkaya A, Yazici AT.

Saudi J Ophthalmol. 2015 Jul-Sep;29(3):232-4. doi: 10.1016/j.sjopt.2015.01.002. Epub 2015 Jan 21.

20.

Comparison of intravitreal ranibizumab between phakic and pseudophakic neovascular age-related macular degeneration patients: Two-year results.

Ozkaya A, Alkin Z, Yilmaz I, Yazici AT.

Saudi J Ophthalmol. 2015 Jul-Sep;29(3):182-6. doi: 10.1016/j.sjopt.2014.12.002. Epub 2014 Dec 13.

21.

Choroidal thickness of children's eyes with anisometropic and strabismic amblyopia.

Aygit ED, Yilmaz I, Ozkaya A, Alkin Z, Gokyigit B, Yazici AT, Demirok A.

J AAPOS. 2015 Jun;19(3):237-41. doi: 10.1016/j.jaapos.2015.03.013.

PMID:
26059669
22.

INTRAVITREAL BEVACIZUMAB IN THE TREATMENT OF CHOROIDAL NEOVASCULAR MEMBRANE DUE TO ANGIOID STREAKS.

Alagöz C, Alagöz N, Özkaya A, Çelik U, Turan MF, Yazici AT, Çekiç O, Demirok A.

Retina. 2015 Oct;35(10):2001-10. doi: 10.1097/IAE.0000000000000605.

PMID:
25996427
23.

CORRELATION OF CHOROIDAL THICKNESS AND BODY MASS INDEX.

Yilmaz I, Ozkaya A, Kocamaz M, Ahmet S, Ozkaya HM, Yasa D, Agca A, Yazici AT, Demirok A.

Retina. 2015 Oct;35(10):2085-90. doi: 10.1097/IAE.0000000000000582.

PMID:
25932552
24.

A case of nodular posterior scleritis mimicking choroidal mass.

Ozkaya A, Alagoz C, Koc A, Ozkaya HM, Yazıcı AT.

Saudi J Ophthalmol. 2015 Apr-Jun;29(2):165-8. doi: 10.1016/j.sjopt.2014.06.012. Epub 2014 Jul 2.

25.

Comparison of intravitreal bevacizumab treatment between phakic and pseudophakic neovascular age-related macular degeneration.

Ozkaya A, Alkin Z, Perente I, Yuksel K, Baz O, Alagoz C, Yazici AT, Demirok A.

Nepal J Ophthalmol. 2014 Jul-Dec;6(2):145-52. doi: 10.3126/nepjoph.v6i2.11706.

PMID:
25680245
26.

Comparison of the Plusoptix A09 and Retinomax K-Plus 3 with retinoscopy in children.

Yilmaz I, Ozkaya A, Alkin Z, Ozbengi S, Yazici AT, Demirok A.

J Pediatr Ophthalmol Strabismus. 2015 Jan-Feb;52(1):37-42. doi: 10.3928/01913913-20141230-06.

PMID:
25643369
27.

Can perifoveal pseudocyst area be a prognostic factor in macular hole surgery?: A prospective study with quantitative data.

Yuksel K, Goker YS, Yazici AT, Ozkaya A, Cosar G.

Medicine (Baltimore). 2014 Dec;93(28):e182. doi: 10.1097/MD.0000000000000182.

28.

Intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks: A report of two patients.

Ozkaya A, Alkin Z, Faiz M, Yazici AT, Demirok A.

Saudi J Ophthalmol. 2014 Oct;28(4):316-8. doi: 10.1016/j.sjopt.2013.07.012. Epub 2013 Jul 23.

29.

Intravitreal ranibizumab for bilateral choroidal neovascularisation in a patient with angioid streaks.

Yilmaz I, Ozkaya A, Alkin Z, Yazici AT.

BMJ Case Rep. 2014 Jul 29;2014. pii: bcr2014204848. doi: 10.1136/bcr-2014-204848.

30.

Selective laser trabeculoplasty for glaucoma secondary to emulsified silicone oil after pars plana vitrectomy: a pilot study.

Alkin Z, Satana B, Ozkaya A, Basarir B, Altan C, Yazici AT, Demirok A.

Biomed Res Int. 2014;2014:469163. doi: 10.1155/2014/469163. Epub 2014 Apr 13.

31.

Focal laser photocoagulation in non-center involved diabetic macular edema.

Perente I, Alkin Z, Ozkaya A, Dardabounis D, Ogreden TA, Konstantinidis A, Kyratzoglou K, Yazici AT.

Med Hypothesis Discov Innov Ophthalmol. 2014 Spring;3(1):9-16.

32.

A single injection of intravitreal ranibizumab in the treatment of choroidal neovascularisation secondary to optic nerve head drusen in a child.

Alkin Z, Ozkaya A, Yilmaz I, Yazici AT.

BMJ Case Rep. 2014 May 2;2014. pii: bcr2014204456. doi: 10.1136/bcr-2014-204456.

33.

Subfoveal choroidal thickness in patients with chronic heart failure analyzed by spectral-domain optical coherence tomography.

Altinkaynak H, Kara N, Sayın N, Güneş H, Avşar S, Yazıcı AT.

Curr Eye Res. 2014 Nov;39(11):1123-8. doi: 10.3109/02713683.2014.898310. Epub 2014 Apr 21.

PMID:
24749809
34.

Comparison of efficacy between low-fluence and half-dose verteporfin photodynamic therapy for chronic central serous chorioretinopathy.

Alkin Z, Perente I, Ozkaya A, Alp D, Agca A, Aygit ED, Korkmaz S, Yazici AT, Demirok A.

Clin Ophthalmol. 2014 Apr 5;8:685-90. doi: 10.2147/OPTH.S58617. eCollection 2014.

35.

Efficacy of selective laser trabeculoplasty in medically uncontrolled glaucoma.

Sayin N, Alkin Z, Ozkaya A, Demir A, Yazici AT, Bozkurt E, Demirok A.

ISRN Ophthalmol. 2013 Jan 8;2013:975281. doi: 10.1155/2013/975281. eCollection 2013.

36.

Bevacizumab versus Ranibizumab on As-Needed Treatment Regimen for Neovascular Age-Related Macular Degeneration in Turkish Patients.

Ozkaya A, Alkin Z, Karakucuk Y, Yasa D, Yazici AT, Demirok A.

ISRN Ophthalmol. 2013 Aug 29;2013:151027. doi: 10.1155/2013/151027. eCollection 2013.

37.

Comparison between Intravitreal Triamcinolone with Grid Laser Photocoagulation versus Bevacizumab with Grid Laser Photocoagulation Combinations for Branch Retinal Vein Occlusion.

Ozkaya A, Celik U, Alkin Z, Faiz Turan M, Yazici AT, Demirok A.

ISRN Ophthalmol. 2013 Dec 19;2013:141279. doi: 10.1155/2013/141279. eCollection 2013.

38.

Early visual and morphologic changes after half-fluence photodynamic therapy in chronic central serous chorioretinopathy.

Alkin Z, Ozkaya A, Agca A, Yazici AT, Demirok A.

J Ocul Pharmacol Ther. 2014 May;30(4):359-65. doi: 10.1089/jop.2013.0162. Epub 2014 Jan 23.

PMID:
24456481
39.

The role of epiretinal membrane on treatment of neovascular age-related macular degeneration with intravitreal bevacizumab.

Alkin Z, Ozkaya A, Osmanbasoglu OA, Agca A, Karakucuk Y, Yazici AT, Demirok A.

ScientificWorldJournal. 2013 Dec 24;2013:958724. doi: 10.1155/2013/958724. eCollection 2013.

40.

Long term result of intravitreal bevacizumab in a patient newly transformed to proliferative macular telangiectasia type 2.

Ozkaya A, Alkin Z, Karakucuk Y, Yazici AT, Demirok A.

Middle East Afr J Ophthalmol. 2013 Oct-Dec;20(4):360-2. doi: 10.4103/0974-9233.120005.

41.

Is spectral-domain optical coherence tomography essential for flexible treatment regimens with ranibizumab for neovascular age-related macular degeneration?

Ozkaya A, Alkin Z, Ozkaya HM, Agca A, Ozgurhan EB, Karakucuk Y, Yazici AT, Demirok A.

J Ophthalmol. 2013;2013:786107. doi: 10.1155/2013/786107. Epub 2013 Nov 11.

42.

Comparison of intravitreal ranibizumab in phakic and pseudophakic neovascular age-related macular degeneration patients with good baseline visual acuity.

Ozkaya A, Alkin Z, Yazici AT, Demirok A.

Retina. 2014 May;34(5):853-9. doi: 10.1097/IAE.0000000000000024.

PMID:
24141904
43.

One-year results of treatment with bevacizumab alone or ranibizumab alone for low visual acuity due to neovascular age-related macular degeneration.

Ozkaya A, Alkin Z, Agca A, Satici T, Karakucuk Y, Yazici AT, Demirok A.

J Ocul Pharmacol Ther. 2013 Dec;29(10):865-9. doi: 10.1089/jop.2013.0106. Epub 2013 Sep 20.

PMID:
24053539
44.

Measurements of anterior segment parameters using three different non-contact optical devices in keratoconus patients.

Yazıcı AT, Pekel G, Bozkurt E, Yıldırım Y, Pekel E, Demirok A, Yılmaz OF.

Int J Ophthalmol. 2013 Aug 18;6(4):521-5. doi: 10.3980/j.issn.2222-3959.2013.04.21. eCollection 2013.

45.

Can intravitreal ranibizumab alter retrobulbar circulation in eyes with age-related macular degeneration?

Yuksel K, Altinkaynak H, Kina A, Kara N, Yazici AT, Demirok A.

J Ocul Pharmacol Ther. 2013 Oct;29(8):723-7. doi: 10.1089/jop.2013.0051. Epub 2013 Jul 5.

PMID:
23829173
46.

Reactivation of ocular toxoplasmosis after pars plana vitrectomy.

Hazar L, Altan C, Basarır B, Yazıcı AT, Oyur G, Demirok A.

Retin Cases Brief Rep. 2013 Fall;7(4):368-70. doi: 10.1097/ICB.0b013e3182964fa5.

PMID:
25383807
47.

Changes in anterior segment morphology after intravitreal injection of bevacizumab and bevacizumab-triamcinolone acetate combination.

Alkin Z, Perente I, Altan C, Konstantinidis A, Ozkaya A, Yuksel K, Yazici AT, Demirok A.

Eur J Ophthalmol. 2013 Jul-Aug;23(4):504-9. doi: 10.5301/ejo.5000241. Epub 2013 May 2.

PMID:
23640509
48.

Diurnal choroidal thickness changes in normal eyes of Turkish people measured by spectral domain optical coherence tomography.

Osmanbasoglu OA, Alkin Z, Ozkaya A, Ozpınar Y, Yazici AT, Demirok A.

J Ophthalmol. 2013;2013:687165. doi: 10.1155/2013/687165. Epub 2013 Mar 27.

49.

Topical nepafenac in treatment of acute central serous chorioretinopathy.

Alkin Z, Osmanbasoglu OA, Ozkaya A, Karatas G, Yazici AT.

Med Hypothesis Discov Innov Ophthalmol. 2013 Winter;2(4):96-101.

50.

Comparing the effects of three different intravitreal injection techniques on vitreous reflux and intraocular pressure.

Özkaya A, Alkin Z, Celik U, Yüksel K, Ozgurhan EB, Ağca A, Yazici AT, Demirok A.

J Ocul Pharmacol Ther. 2013 Apr;29(3):325-9. doi: 10.1089/jop.2012.0144. Epub 2012 Nov 15.

PMID:
23153049

Supplemental Content

Loading ...
Support Center